Reset filters
  • 13 July 2004

Two-year data continue to show promise for T-20

Read the article
  • 12 July 2004

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients

Read the article
  • 12 July 2004

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

Read the article
  • 12 July 2004

Efavirenz can be used at normal dose with rifampicin, Thais report

Read the article
  • 12 July 2004

WHO: we are still on track for 3 x 5 HIV treatment goal

Read the article
  • 12 July 2004

Taking HAART not associated with sexual risk taking, but belief that HAART makes HIV less infectious is, finds meta-analysis

Read the article
  • 9 July 2004

Azithromycin resistant syphilis found in HIV-positive gay men

Read the article
  • 9 July 2004

Long-term stress suppresses immune system, particularly in those who are sick, finds meta-analysis

Read the article
  • 8 July 2004

HIV could have catastrophic economic consequences for Asia/Pacific, warns report

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.